
Combinent Biomedical Systems
Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.
Employees
Enterprise value
$4—6m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | $600k | Debt | |
Total Funding | 000k |
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads